MICROINJECTION STUDIES ON PROTEIN DEGRADATION

蛋白质降解的微注射研究

基本信息

  • 批准号:
    3274575
  • 负责人:
  • 金额:
    $ 23.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1980
  • 资助国家:
    美国
  • 起止时间:
    1980-01-01 至 1994-12-31
  • 项目状态:
    已结题

项目摘要

The long term objective of this proposal os to elucidate the mechanisms by which cells selectively degrade their intracellular proteins and to discover the features of protein that promote their catabolism. Two cell systems are available in which it is possible to eliminate either proline endopeptidase or ubiquitin (Ub) conjugation. Individual, radiolabeled proteins will be injected into each cell line to determine which proteins are substrates for these pathways. This procedure has already revealed that ubiquitin and bovine serum albumin ar stabilized in cells lacking proline endopeptidase and that oxidized hemoglobin is stabilized in ts85 mouse cells which contain a labile Ub-activating enzyme. The half-lives of a series of temperature-sensitive T4 lysozymes will also be measured to test the hypothesis that thermodynamic stability correlates with metabolic stability. Surprisingly, T4 lysozyme is degraded very rapidly in HeLa cells, and we will determine whether surface cysteines or arginine-arginine pairs are responsible for its short life. In addition, specific proteins will be targeted to the nucleus to discover whether their degradation rates are affected by mislocalization. Finally, ubiquitin will be injected into ts85 mouse cells or HeLa cells and several aspects of Ub metabolism will be measured, including Ub's role in autophagy and release of injected proteins, as well as the subcellular location of Ub conjugates before and after heat-shock.
本建议的长期目标是通过以下方式阐明这些机制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTIN C RECHSTEINER其他文献

MARTIN C RECHSTEINER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTIN C RECHSTEINER', 18)}}的其他基金

Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
  • 批准号:
    6826106
  • 财政年份:
    2004
  • 资助金额:
    $ 23.72万
  • 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
  • 批准号:
    7056150
  • 财政年份:
    2004
  • 资助金额:
    $ 23.72万
  • 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
  • 批准号:
    6898835
  • 财政年份:
    2004
  • 资助金额:
    $ 23.72万
  • 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
  • 批准号:
    7216180
  • 财政年份:
    2004
  • 资助金额:
    $ 23.72万
  • 项目类别:
Proteasomes, PODs and Polyglutamine Diseases
蛋白酶体、POD 和多聚谷氨酰胺疾病
  • 批准号:
    7391680
  • 财政年份:
    2004
  • 资助金额:
    $ 23.72万
  • 项目类别:
MOLECULAR DISSECTION OF A PROTEASOME ACTIVATOR
蛋白酶体激活剂的分子解剖
  • 批准号:
    6030326
  • 财政年份:
    2000
  • 资助金额:
    $ 23.72万
  • 项目类别:
MOLECULAR DISSECTION OF A PROTEASOME ACTIVATOR
蛋白酶体激活剂的分子解剖
  • 批准号:
    6627253
  • 财政年份:
    2000
  • 资助金额:
    $ 23.72万
  • 项目类别:
MOLECULAR DISSECTION OF A PROTEASOME ACTIVATOR
蛋白酶体激活剂的分子解剖
  • 批准号:
    6343087
  • 财政年份:
    2000
  • 资助金额:
    $ 23.72万
  • 项目类别:
MOLECULAR DISSECTION OF A PROTEASOME ACTIVATOR
蛋白酶体激活剂的分子解剖
  • 批准号:
    6490196
  • 财政年份:
    2000
  • 资助金额:
    $ 23.72万
  • 项目类别:
PROPERTIES OF AN ATP/UBIQUITIN-DEPENDENT PROTEASE
ATP/泛素依赖性蛋白酶的特性
  • 批准号:
    6329672
  • 财政年份:
    1986
  • 资助金额:
    $ 23.72万
  • 项目类别:

相似海外基金

Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
  • 批准号:
    10685312
  • 财政年份:
    2021
  • 资助金额:
    $ 23.72万
  • 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
  • 批准号:
    10490872
  • 财政年份:
    2021
  • 资助金额:
    $ 23.72万
  • 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
  • 批准号:
    10345963
  • 财政年份:
    2021
  • 资助金额:
    $ 23.72万
  • 项目类别:
Development of Highly Functionalized Serum Albumins as Boron Delivery Carries to Tumor for Neutron Capture Therapy
开发高功能化血清白蛋白作为硼输送至肿瘤以进行中子捕获治疗
  • 批准号:
    17H02202
  • 财政年份:
    2017
  • 资助金额:
    $ 23.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on Asymmetric Nitroaldol Reaction using mutant albumins
突变体白蛋白不对称硝醛醇反应的研究
  • 批准号:
    16K05706
  • 财政年份:
    2016
  • 资助金额:
    $ 23.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SPIN LABELING STUDIES OF NORMAL RECOMBINANT & MUTANT HUMAN SERUM ALBUMINS
正常重组的旋转标记研究
  • 批准号:
    6118869
  • 财政年份:
    1999
  • 资助金额:
    $ 23.72万
  • 项目类别:
COPPER BINDING OF COMMERCIAL, NORMAL RECOMBINANT, & MUTANT HUMAN SERUM ALBUMINS
商业、正常重组的铜结合,
  • 批准号:
    6118864
  • 财政年份:
    1999
  • 资助金额:
    $ 23.72万
  • 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia in Fowl
家禽双清蛋白血症血清白蛋白的结构与代谢特征
  • 批准号:
    67B6472
  • 财政年份:
    1967
  • 资助金额:
    $ 23.72万
  • 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia
双清蛋白血症血清白蛋白的结构和代谢特征
  • 批准号:
    65B3344
  • 财政年份:
    1965
  • 资助金额:
    $ 23.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了